A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 138 participants.

Also called NCT04175600

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 138 participants (enrolled count) (from the registry)
Sponsor
  • Actelion Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04175600
  • EudraCT 2019-002817-21
  • EU CT 2022-501012-34-00
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Colombia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Lithuania, Malaysia, Mexico, Poland, Portugal, Russia, Serbia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, Türkiye, Ukraine, Vietnam (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04175600. Randomized; double masking; primary purpose treatment. Start 2020-01-16 (actual); primary completion 2024-10-11 (actual). Results posted on 2026-07-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension
Acronym
SALTO
Condition
Hypertension, Pulmonary
Intervention (Drug)
Selexipag
Intervention (Drug)
Placebo
Intervention (Drug)
Standard of Care (SOC): Endothelin receptor antagonist
Intervention (Drug)
SOC: Phosphodiesterase type 5 (PDE-5) inhibitor
Intervention (Drug)
SOC: Soluble guanylate cyclase stimulator
Lead sponsor
Actelion (class: industry)

Record details

Record id
cardio:ct-nct04175600
Content hash
8c546d47f62ff3fb6715108bf661eafc064d814978ab8700db891d633a48bd84